Notice Regarding the Recognition of Non-operating Income (Subsidy Income)
FunPep Company Limited (submitting company)
Subcontracted research and development agreement relating to drug discovery using single-cell genomics for heart failure
The University of Tokyo notified the company that it had received the results of the final inspection of the subcontracting expenses carried forward from fiscal 2024 to fiscal 2025. As a result, the advance payments received for that fiscal year were reclassified as non-operating income.
¥1,181 thousand (non-operating income)
Cumulative second-quarter period of the fiscal year ending December 2026 (1 January 2026 to 30 June 2026)
Related procedures
Final inspection of subcontracting expenses
Japan Agency for Medical Research and Development (AMED), University of Tokyo
| Item | Details |
|---|---|
| Event name | Notice Regarding the Recognition of Non-operating Income (Subsidy Income) |
| Subject Entity | FunPep Company Limited (submitting company) |
| Target Locations / Products | Subcontracted research and development agreement relating to drug discovery using single-cell genomics for heart failure |
| Cause | The University of Tokyo notified the company that it had received the results of the final inspection of the subcontracting expenses carried forward from fiscal 2024 to fiscal 2025. As a result, the advance payments received for that fiscal year were reclassified as non-operating income. |
| Amount of Impact on Business Performance | ¥1,181 thousand (non-operating income) |
| Accounting period in which recognized | Cumulative second-quarter period of the fiscal year ending December 2026 (1 January 2026 to 30 June 2026) |
| Type of litigation or proceeding | Final inspection of subcontracting expenses |
| Court or authority | Japan Agency for Medical Research and Development (AMED), University of Tokyo |
Items this document does not state (17)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The University of Tokyo notified the company that it had received the results of the final inspection of the subcontracting expenses carried forward from fiscal 2024 to fiscal 2025.